DRUG: IPH6501
DRUG: Pembrolizumab
DRUG: Doxorubicin
DRUG: Vinblastine
DRUG: Dacarbazine
DRUG: Brentuximab vedotin
BIOLOGICAL: ATLCAR.CD30 cells
DRUG: LP-168
DRUG: LP-168
DRUG: Pembrolizumab
DRUG: Flt3L
RADIATION: Radiation
DRUG: Poly ICLC
DRUG: MT-601
DRUG: Pembrolizumab
DRUG: R-CHOP Protocol
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
OTHER: Electronic Health Record Review
BIOLOGICAL: Epcoritamab
DRUG: Lenalidomide
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: HST-NEETs
BIOLOGICAL: Bone Marrow Transplant
DRUG: Belinostat
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
OTHER: Pharmacokinetic Study
PROCEDURE: Positron Emission Tomography and Computed Tomography Scan
DRUG: Tazemetostat
DRUG: Polatuzumab vedotin
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Prednisone
DRUG: Odronextamab
BIOLOGICAL: Peripheral Blood Stem Cell Transplant
DRUG: Allopurinol 300 MG
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: Bone Marrow Cell Transplant
RADIATION: Total Body Irradiation
DRUG: Sirolimus Pill
DRUG: Mycophenolate Mofetil
DRUG: WTX-330
DRUG: APG-5918
DRUG: Methotrexate
DRUG: pralatraxate,
DRUG: Ifosfamide
DRUG: Dexamethasone
DRUG: Etoposide
DRUG: calaspargase pegol
DRUG: cyclophosphamide
DRUG: Doxorubicin
DRUG: Prednisone
DRUG: Brentuximab Vedotin
DRUG: Rituximab
DRUG: Lenalidomide
DRUG: Valemetostat
DRUG: BET Bromodomain Inhibitor ZEN-3694
PROCEDURE: Core Biopsy
DRUG: Entinostat
DRUG: Tazemetostat
DRUG: Tazemetostat
DRUG: Placebo oral tablet
COMBINATION_PRODUCT: Lenalidomide
COMBINATION_PRODUCT: Rituximab
BIOLOGICAL: CD19/CD22 CAR T-Cells
DRUG: Fludarabine
DRUG: Cyclophosphamide
GENETIC: ADI-001
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: Zilovertamab vedotin
DRUG: Nemtabrutinib
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
PROCEDURE: Computed Tomography
RADIATION: External Beam Radiation Therapy
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: Mosunetuzumab
DRUG: Zanubrutinib
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: ACE1831
DRUG: Obinutuzumab
BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Lenalidomide
DRUG: Rituximab
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: Bendamustine
DRUG: Nemtabrutinib
DRUG: Mosunetuzumab
DRUG: Lenalidomide
DRUG: Rituximab
DRUG: Tociluzumab
PROCEDURE: Hematopoietic Cell Transplantation
DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus
DRUG: Cyclophosphamide
RADIATION: Total-Body Irradiation
PROCEDURE: Donor Lymphocyte Infusion
DRUG: Fludarabine
DRUG: Melphalan
PROCEDURE: Bone Marrow Biopsy
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Prednisone
BIOLOGICAL: Retifanlimab
BIOLOGICAL: Rituximab and Hyaluronidase Human
BIOLOGICAL: Tafasitamab
DRUG: Vincristine
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Multigated Acquisition Scan
OTHER: Fludeoxyglucose F-18
PROCEDURE: Positron Emission Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Biospecimen Collection
DRUG: Polatuzumab Vedotin
DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: Axi-cel
BIOLOGICAL: EB103
DRUG: Ruxolitinib
DRUG: Nivolumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
RADIATION: Radiation Therapy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
BIOLOGICAL: Ipilimumab
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
GENETIC: CAR T Cells
BIOLOGICAL: Anti-CD19/CD20/CD22 CAR T-Cells
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
DRUG: Carboplatin
PROCEDURE: Computed Tomography
DRUG: Etoposide
DRUG: Ifosfamide
DRUG: Lenalidomide
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tafasitamab
DRUG: Acalabrutinib
BIOLOGICAL: Axicabtagene Ciloleucel
BIOLOGICAL: EO2463
DRUG: lenalidomide
BIOLOGICAL: rituximab
BIOLOGICAL: NKX019
DRUG: ABBV-525
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
BIOLOGICAL: Rituximab
BIOLOGICAL: MABEL CTLs
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Lisocabtagene Maraleucel
DRUG: Polymer-conjugated IL-15 Receptor Agonist NKTR-255
PROCEDURE: X-Ray Imaging
PROCEDURE: Echocardiography
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Lumbar Puncture
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Biospecimen Collection
PROCEDURE: Biopsy
DRUG: Pembrolizumab
DRUG: Pralatrexate
DRUG: Decitabine
OTHER: Clinical Observation
RADIATION: Radiation Therapy
BIOLOGICAL: Rituximab
DIETARY_SUPPLEMENT: Cholecalciferol
OTHER: Laboratory Biomarker Analysis
DRUG: Isatuximab
OTHER: Standard Procedures
DRUG: CD22CART Infusion
DRUG: Asparaginase Erwinia chrysanthemi
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Calaspargase Pegol
DRUG: Cyclophosphamide
DRUG: Cytarabine
PROCEDURE: Diagnostic Imaging
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Leucovorin Calcium
PROCEDURE: Lumbar Puncture
DRUG: Methotrexate
DRUG: Pegaspargase
DRUG: Vincristine
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Cyclophosphamide
DRUG: Cyclosporine
BIOLOGICAL: Filgrastim
DRUG: Fludarabine
DRUG: Mycophenolate Mofetil
DRUG: Mycophenolate Sodium
RADIATION: Total-Body Irradiation
DRUG: Treosulfan
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
DRUG: Tegavivint
DRUG: CC-99282
DRUG: Rituximab
DRUG: Obinutuzumab
DRUG: Tafasitamab
DRUG: Valemetostat
BIOLOGICAL: Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563
DRUG: Bendamustine
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
PROCEDURE: Extracorporeal Photopheresis
BIOLOGICAL: Mogamulizumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: Brentuximab vedotin
PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Rituximab
DRUG: Azacytidine
DRUG: Pembrolizumab
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Loncastuximab Tesirine
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Positron Emission Tomography
GENETIC: KUR-502
DRUG: DA-EPOCH
BIOLOGICAL: Rituximab
DRUG: CHOP
DRUG: Acalabrutinib
DRUG: Venetoclax
DRUG: Dexamethasone
DRUG: Inotuzumab Ozogamicin
BIOLOGICAL: Fully human anti CD19 CAR-T Cell Dose
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
DRUG: rituximab and lenalidomide
DRUG: rituximab and bendamustine
DRUG: rituximab, cytarabine, dexamethasone, and oxaliplatin/carboplatin
DRUG: gemcitabine and oxaliplatin
BIOLOGICAL: Epcoritamab
DRUG: rituximab, cyclophosphamide, reduced dose of doxorubicin, vincristine, and prednisone
DRUG: Lenalidomide
DRUG: rituximab, ifosfamide, carboplatin, and etoposide phosphate
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
DRUG: E7777
DRUG: Cyclophosphamide injection
DRUG: Fludarabine Injection
BIOLOGICAL: CD19-CD34t metabolically programmed CAR transduced T-cells
DRUG: Mervometostat (PF-06821497)
DRUG: Enzalutamide
DRUG: Odronextamab
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone/prednisolone
DRUG: Bendamustine
DEVICE: Vysis LSI MYC Break Apart Rearrangement Probe Kit
DRUG: venetoclax
DRUG: VIP152
DRUG: prednisone
DRUG: Mosunetuzumab
DRUG: Polatuzumab vedotin
DRUG: Tocilizumab
DRUG: Rituximab
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Prednisone
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Epcoritamab
DRUG: Polatuzumab Vedotin
BIOLOGICAL: Rituximab
DRUG: Prednisone
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Cyclophosphamide
BIOLOGICAL: Filgrastim
DRUG: Conditioning Chemotherapy
BIOLOGICAL: Cord blood graft
GENETIC: CD19.CAR-aNKT cells
DRUG: Hypericin
OTHER: Visible Light
DRUG: Emavusertib
DRUG: ibrutinib
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Bone Scan
PROCEDURE: Computed Tomography
DRUG: Ensartinib
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Magnetic Resonance Imaging
OTHER: Pharmacological Study
PROCEDURE: Positron Emission Tomography
PROCEDURE: Radionuclide Imaging
PROCEDURE: X-Ray Imaging
GENETIC: CD7.CAR/28zeta CAR T cells
DRUG: Epcoritamab
DRUG: Rituximab
DRUG: IDP-023
DRUG: Rituximab
DRUG: Daratumumab
DRUG: Interleukin-2
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Mesna
BIOLOGICAL: Basiliximab
DRUG: Carmustine
DRUG: Cytarabine
DRUG: Etoposide
BIOLOGICAL: Genetically Engineered Hematopoietic Stem Progenitor Cells
BIOLOGICAL: Recombinant Granulocyte Colony-Stimulating Factor
BIOLOGICAL: Yttrium Y 90 Basiliximab
DRUG: Zanubrutinib
BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Cyclophosphamide
BIOLOGICAL: Cytokine-treated Veto Cells
DRUG: Fludarabine
PROCEDURE: Peripheral Blood Stem Cell Transplantation
RADIATION: Total-Body Irradiation
DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: Lenalidomide
DRUG: Acalabrutinib
BIOLOGICAL: Obinutuzumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
PROCEDURE: Computed Tomography
PROCEDURE: Endoscopic Procedure
RADIATION: Involved-site Radiation Therapy (3 Fractions)
RADIATION: Involved-site Radiation Therapy (12 Fractions)
PROCEDURE: Positron Emission Tomography
OTHER: Questionnaire Administration
DRUG: NX-2127
BIOLOGICAL: CD19/CD22-CAR-transduced T cells
DRUG: cyclophosphamide
DRUG: fludarabine
BIOLOGICAL: Axicabtagene Ciloleucel
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Lisocabtagene Maraleucel
BIOLOGICAL: Mosunetuzumab
OTHER: Patient Observation
DRUG: Polatuzumab Vedotin
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tisagenlecleucel
DRUG: Anti-thymocyte globulin (rabbit)
DRUG: Blinatumomab
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: G-CSF
DRUG: Melphalan
DRUG: Mesna
DRUG: Rituximab
DRUG: Tacrolimus
DRUG: Thiotepa
BIOLOGICAL: HPC,A Infusion
DEVICE: CliniMACS
DRUG: Sirolimus
DRUG: voruciclib monotherapy
DRUG: voruciclib and venetoclax
DRUG: SC Mosunetuzumab
DRUG: IV Glofitamab
DRUG: CC-220
DRUG: CC-99282
DRUG: Obinutuzumab
DRUG: Tocilizumab
DRUG: Selinexor
DRUG: Zanubrutinib
DRUG: Tafasitamab
BIOLOGICAL: CNTY-101
BIOLOGICAL: IL-2
DRUG: Lymphodepleting Chemotherapy
DRUG: Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
DRUG: Bendamustine Hydrochloride
DRUG: Brentuximab Vedotin
BIOLOGICAL: Autologous BAFFR-targeting CAR T Cells
DRUG: Bendamustine
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: Obinutuzumab
DRUG: CC-99282
DRUG: Mogamulizumab
DRUG: Brentuximab vedotin
BIOLOGICAL: Pneumococcal conjugate vaccine (PCV13)
BIOLOGICAL: CD19 targeted CAR T Cell Therapy
DRUG: CD47 Antagonist ALX148
DRUG: Lenalidomide
BIOLOGICAL: Rituximab
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Lenalidomide
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
BIOLOGICAL: Tafasitamab
DRUG: Tazemetostat
DRUG: Zanubrutinib
DRUG: Polatuzumab vedotin
DRUG: AZD0486 IV
PROCEDURE: Haploidentical Bone Marrow/Kidney
GENETIC: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells
GENETIC: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells
DRUG: Fludarabine (Conditional therapy)
DRUG: Cyclophosphamide Monohydrate (Conditional therapy)
DRUG: firi-cel (Experimental drug)
BIOLOGICAL: Kappa CD28 T cells
DRUG: ONO-4685
DRUG: DPX-Survivac
DRUG: Pembrolizumab
DRUG: CPA
BIOLOGICAL: Zilovertamab vedotin
BIOLOGICAL: Rituximab
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Bendamustine
DRUG: AB-101
DRUG: Rituximab
DRUG: Interleukin-2
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Bendamustine
PROCEDURE: AutoSCT OR CAR T-cell Therapy
DRUG: GDP
DRUG: Epcoritamab
BIOLOGICAL: Nivolumab
BIOLOGICAL: Pembrolizumab
DRUG: Ritlecitinib
DRUG: Venetoclax
DRUG: Lenalidomide
DRUG: Rituximab
DRUG: Tagraxofusp
DRUG: Fludarabine
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Vincristine
DRUG: Azacitidine
DRUG: Methotrexate
DRUG: Cytarabine IT
DRUG: Hydrocortisone
DRUG: Etoposide
DRUG: BCNU
DRUG: AraC
DRUG: Melphalan
PROCEDURE: Peripheral blood stem cell transplantation
BIOLOGICAL: G-CSF
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Daratumumab SC
DRUG: Loncastuximab tesirine
DRUG: Venetoclax
BIOLOGICAL: Azer-cel
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: IL-2
DRUG: Bendamustine
DRUG: Obinutuzumab
DRUG: Glofitamab
DRUG: Rituximab
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide
DRUG: Tocilizumab
DRUG: Parsaclisib
DRUG: parsaclisib + itacitinib
DRUG: parsaclisib + ruxolitinib
DRUG: parsaclisib + ibrutinib
BIOLOGICAL: UCART20x22
BIOLOGICAL: CLLS52
DRUG: Acalabrutinib
DRUG: Bortezomib
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Doxorubicin Hydrochloride
DRUG: Prednisone
BIOLOGICAL: Rituximab
BIOLOGICAL: Rituximab and Hyaluronidase Human
DRUG: Ibrutinib
BIOLOGICAL: Obinutuzumab
DRUG: Venetoclax
DRUG: Relatlimab
DRUG: Nivolumab
DRUG: Brentuximab Vedotin
PROCEDURE: Hematopoietic Cell Transplantation
BIOLOGICAL: Nivolumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
PROCEDURE: TCRαβ+/CD19+ depleted Haploidentical HSCT
DRUG: Zoledronate
DRUG: Mosunetuzumab
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: PRGN-3007
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Mogamulizumab
BIOLOGICAL: Natural Killer Cell Therapy
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: ABBV-319
DRUG: Venetoclax
DRUG: Azacitidine
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Hydrocortisone
DRUG: Leucovorin
DRUG: Dexamethasone
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Dexrazoxane
DRUG: Calaspargase Pegol
DRUG: Erwinia asparaginase
DEVICE: CliniMACS
BIOLOGICAL: Allogeneic Natural Killer Cell Line NK-92
BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Busulfan
DRUG: Clofarabine
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
OTHER: Laboratory Biomarker Analysis
DRUG: Melphalan
BIOLOGICAL: Rituximab
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
DRUG: Efineptakin alfa
DRUG: Tisagenlecleucel
DRUG: Axicabtagene ciloleucel
DRUG: Lisocabtagene Maraleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: KITE-363
BIOLOGICAL: KITE-753
DRUG: Acalabrutinib
DRUG: Rituximab
OTHER: Brexucabtagene Autoleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
DRUG: KITE-197
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Chemotherapy
BIOLOGICAL: Cell infusion
BIOLOGICAL: BEAM-201
DRUG: Acalabrutinib
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Lenalidomide
DRUG: Prednisone
BIOLOGICAL: Rituximab
BIOLOGICAL: Tafasitamab
DRUG: Vincristine
DRUG: KT-333
BIOLOGICAL: Dose Level 1A: 2 x 10^7 cells/m2
BIOLOGICAL: Dose Level 2A: 6 x 10^7 cells/m2
BIOLOGICAL: Dose Level 2B: 6 x 10^7 cells/m2
BIOLOGICAL: Dose Level 3B: 2 x 10^8 cells/m2
BIOLOGICAL: Dose Level 3A: 2 x 10^8 cells/m2
BIOLOGICAL: iC9-CAR19 T cells
DRUG: Bendamustine
DRUG: Fludarabine
DRUG: AP1903
DRUG: Cyclophosphamide
DRUG: Choline Salicylate
DRUG: Selinexor
DRUG: Hyperbaric oxygen
DRUG: Golcadomide
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: Bendamustine
DRUG: ATA3219
RADIATION: Viewray MRIdian® Linac
DRUG: Mosunetuzumab
DRUG: Lenalidomide
DRUG: Odronextamab
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone/Prenisolone
DRUG: CTX-8371
DRUG: SC291
DRUG: Brentuximab vedotin
DRUG: Pembrolizumab
BIOLOGICAL: pembrolizumab
BIOLOGICAL: Favezelimab
DRUG: Tazemetostat Pill
DRUG: Mogamulizumab-Kpkc
DEVICE: Phototherapy
DRUG: Iopofosine I 131 single dose
DRUG: Iopofosine I 131 multiple dose
DRUG: Iopofosine I 131 fractionated dose
DRUG: Loncastuximab Tesirine
DRUG: Rituximab
DRUG: Gemcitabine
DRUG: Oxaliplatin
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Decitabine and Cedazuridine
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DRUG: Zanubrutinib
DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: Tocilizumab
DRUG: Rituximab
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide
DRUG: BGB-16673
DRUG: 131-I Apamistamab
BIOLOGICAL: CAR T-cell
DRUG: ATL-RIC
DRUG: mRIC
PROCEDURE: allo HCT
DRUG: RIC
DRUG: GVHD prophylaxis
DRUG: IOC
RADIATION: Involved site radiotherapy
DRUG: Doxorubicin
DRUG: Bleomycin
DRUG: Brentuximab vedotin
DRUG: Vinblastine
DRUG: Dacarbazine
DRUG: Haematopoietic growth factor
BIOLOGICAL: CTX112
BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Etoposide
DRUG: Rituximab
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Dacarbazine
DRUG: Doxorubicin
PROCEDURE: Echocardiography
PROCEDURE: Multigated Acquisition Scan
BIOLOGICAL: Pembrolizumab
PROCEDURE: Positron Emission Tomography
DRUG: Vinblastine
DRUG: KB-0742
DRUG: IKS03
BIOLOGICAL: Obinutuzumab
BIOLOGICAL: Glofitamab
DRUG: Pirtobrutinib
PROCEDURE: Tumor Imaging
PROCEDURE: Biospecimen Collection
DEVICE: ClonoSeq Assay
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Biospecimen Collection
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Oral Azacitidine
DRUG: Prednisone
OTHER: Questionnaire Administration
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Positron Emission Tomography
OTHER: Questionnaire Administration
BIOLOGICAL: 19(T2)28z1xx TRAC T cell
DRUG: Acalabrutinib
BIOLOGICAL: CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspirate
DRUG: Cyclophosphamide
DRUG: Cyclosporine
PROCEDURE: Diagnostic Imaging
PROCEDURE: Echocardiography
DRUG: Fludarabine Phosphate
PROCEDURE: Multigated Acquisition Scan
DRUG: Mycophenolate Mofetil
OTHER: Survey Administration
DRUG: Thiotepa
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
BIOLOGICAL: ATLCAR.CD30 T cells
DRUG: Bendamustine
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: DOC Group B
DRUG: Pv-COMRAD 1 and 2 Group B
DRUG: Pv-R-CYM 1 and 2 Group B
DRUG: DOC Group C
DRUG: MAD CPR 1 and 2
DRUG: Pv-R CYVE 1 and 2
DRUG: Pv-R CYVE-MTX 1 and 2
DRUG: MAD CP
DRUG: Pv-Cytarabine/etoposide
DRUG: AD CP
DRUG: Bv-AVD-R 1 and 2: COHORT IIa
DRUG: Bv-NVD-R, Cycle 1-2
DRUG: Bv-NVD-R, Cycle 1-4 SER
DRUG: Bv-AVD-R
DRUG: Bv-NVD-R, Cycle 1-4 RER
DRUG: Bv-NAVD-R, Cycle 1-2
RADIATION: Involved Site Radiation Therapy
RADIATION: Bridging radiotherapy (BRT)
DRUG: Conditioning chemotherapy
BIOLOGICAL: CAR T-cell product
RADIATION: Ultra Low Dose 4 Gy Radiation
DRUG: Bortezomib
DRUG: Clofarabine
DRUG: Cyclophosphamide
DRUG: Dexamethasone
DRUG: Etoposide
BIOLOGICAL: Ofatumumab
BIOLOGICAL: Pegfilgrastim
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate Liposome
DRUG: Axatilimab
DRUG: Nivolumab
DRUG: SGN-35C
DRUG: Acalabrutinib
DRUG: Venetoclax
DRUG: Obinutuzumab
DRUG: Englumafusp alfa
DRUG: Obinutuzumab
DRUG: Glofitamab
DRUG: Tocilizumab
DRUG: Siltuximab
DRUG: Venetoclax Oral Tablet [Venclexta]
DRUG: pembrolizumab
DRUG: gemcitabine
DRUG: vinorelbine
DRUG: liposomal doxorubicin
PROCEDURE: Stem cell mobilization and collection
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
BIOLOGICAL: Glofitamab
DRUG: Lenalidomide
BIOLOGICAL: Obinutuzumab
PROCEDURE: Positron Emission Tomography
DRUG: Venetoclax
DRUG: Axicabtagene Ciloleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine phosphate
DRUG: Prednisone
DRUG: Diphenhydramine
DRUG: Acetaminophen
DRUG: EZM0414
DRUG: Ibrutinib
DRUG: Pembrolizumab
DRUG: BGB-11417
DIETARY_SUPPLEMENT: Ascorbic Acid
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Etoposide
DRUG: Gemcitabine Hydrochloride
DRUG: Ifosfamide
OTHER: Laboratory Biomarker Analysis
DRUG: Oxaliplatin
OTHER: Placebo Administration
OTHER: Questionnaire Administration
BIOLOGICAL: Rituximab
DRUG: Decitabine
PROCEDURE: Biospecimen Collection
PROCEDURE: Core Biopsy
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Central Venous Cannula Insertion
PROCEDURE: Portacath Placement
PROCEDURE: Computed Tomography
GENETIC: ALLO-501A
BIOLOGICAL: ALLO-647
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Pembrolizumab
DRUG: Mogamulizumab
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Golcadomide
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
DRUG: Odronextamab
DRUG: Lenalidomide
DRUG: Rituximab
DRUG: BMS-986458
DRUG: Rituximab
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Ontorpacept
BIOLOGICAL: Pembrolizumab
PROCEDURE: Positron Emission Tomography
DRUG: Maplirpacept
DRUG: mosunetuzumab
DRUG: glofitamab
DRUG: obinutuzumab
DRUG: Mosunetuzumab (Cohorts A-C)
DRUG: Mosunetuzumab (Cohorts D-E)
DRUG: Tocilizumab
DRUG: Loncastuximab tesirine 150 µg/Kg
DRUG: Loncastuximab tesirine 75µg/Kg
DRUG: Zanubrutinib
DRUG: Rituximab
DRUG: Mosunetuzumab
DRUG: Polatuzumab vedotin
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
BIOLOGICAL: Rituximab and Hyaluronidase Human
DRUG: Imiquimod
RADIATION: Radiation Therapy
BIOLOGICAL: SIRPant-M
RADIATION: External-beam radiotherapy (XRT)
DRUG: HCB101
BIOLOGICAL: AUTO1
DRUG: Gemcitabine
DRUG: Pembrolizumab
BIOLOGICAL: obinutuzumab
DRUG: prednisone
DRUG: Revlimid
BIOLOGICAL: Polatuzumab
DRUG: ibrutinib
DRUG: venetoclax
DRUG: Obinutuzumab
DRUG: Glofitamab
DRUG: Rituximab
DRUG: Bendamustine
DRUG: Lenalidomide
DRUG: Tocilizumab
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
OTHER: Fludeoxyglucose F-18
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
BIOLOGICAL: Rituximab and Hyaluronidase Human
DRUG: Mosunetuzumab
DRUG: Polatuzumab vedotin
DRUG: Tafasitamab
DRUG: Lenalidomide
DRUG: CD19x22 CAR T Cells
BIOLOGICAL: Anti-CD19-CAR CMV-specific T-lymphocytes
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Leukapheresis
PROCEDURE: Lymphodepletion Therapy
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Positron Emission Tomography
PROCEDURE: X-Ray Imaging
DRUG: Mogamulizumab
RADIATION: LD TSEBT
DRUG: Brentuximab Vedotin
DRUG: Cyclophosphamide
DRUG: Doxorubicin
BIOLOGICAL: Nivolumab
DRUG: Prednisone
OTHER: Quality-of-Life Assessment
BIOLOGICAL: Rituximab
DRUG: Bendamustine
DRUG: Rituximab
DRUG: Tazemetostat
DRUG: ACALABRUTINIB
DRUG: LISOCABTAGENE MARALEUCEL
DRUG: Lymphodepleting chemotherapy
DRUG: APG-115
DRUG: APG-2575
DRUG: AFM13
DRUG: AB-101
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Interleukin-2
DRUG: Duvelisib
BIOLOGICAL: Tisagenlecleucel
DRUG: Brentuximab Vedotin
BIOLOGICAL: Nivolumab
DRUG: Brentuximab Vedotin
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Nivolumab
DRUG: Fludarabine
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Cyclosporine A
DRUG: Mycophenylate mofetil
BIOLOGICAL: Umbilical cord blood
DRUG: ONO-7018
DRUG: ONO-7018
DRUG: ABBV-101
DRUG: BAFF CAR-T
BIOLOGICAL: BI-1206
DRUG: Venetoclax
DRUG: Ibrutinib
DRUG: Prednisone
BIOLOGICAL: Obinutuzumab
DRUG: Revlimid (lenalidomide)
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Bleomycin Sulfate
DRUG: Brentuximab Vedotin
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Dacarbazine
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
DRUG: Etoposide Phosphate
OTHER: Fludeoxyglucose F-18
RADIATION: Involved-site Radiation Therapy
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
DRUG: Prednisolone
DRUG: Prednisone
DRUG: Procarbazine Hydrochloride
OTHER: Questionnaire Administration
DRUG: Vinblastine Sulfate
DRUG: Vincristine Sulfate
DRUG: Epcoritamab
GENETIC: Autologous CD5.CAR/28zeta CAR T cells
GENETIC: Allogeneic CD5.CAR/28zeta CAR T cells
DEVICE: Miltenyi CliniMACS Prodigy ® system
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Leukapheresis
BIOLOGICAL: Lisocabtagene Maraleucel
PROCEDURE: Lymph Node Biopsy
PROCEDURE: Positron Emission Tomography
DRUG: Zanubrutinib
DRUG: Brentuximab vedotin
DRUG: Doxorubicin Hydrochloride
DRUG: Pembrolizumab
DRUG: Dacarbazine
BIOLOGICAL: TAA-specific CTLs
DRUG: CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Mosunetuzumab
DRUG: Polatuzumab Vedotin
PROCEDURE: Positron Emission Tomography
OTHER: Questionnaire Administration
BIOLOGICAL: zamtocabtagene autoleucel (MB-CART2019.1)
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Bendamustine
DRUG: Epcoritamab
DRUG: Prednisone
DRUG: Rituximab
DRUG: Lenalidomide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Cyclophosphamide
DRUG: Obinutuzumab
DRUG: Bendamustine
BIOLOGICAL: bbT369
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Lenalidomide
PROCEDURE: Lumbar Puncture
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tafasitamab
DRUG: Venetoclax
DRUG: Loncastuximab tesirine
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: Etoposide
DRUG: Duvelisib
DRUG: Oral azacitidine
BIOLOGICAL: autologous hematopoietic stem cells added to planned CAR T
OTHER: Pharmacokinetics
OTHER: Pharmacokinetics
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Dexamethasone
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Methotrexate
DRUG: Cytarabine
DRUG: Methylprednisolone
BIOLOGICAL: Rituximab
DRUG: Prednisone
DRUG: Mercaptopurine
DRUG: Doxorubicin
DRUG: 1A46 Injection
DRUG: bendamustine
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Bleomycin
DRUG: Vincristine
DRUG: Vinblastine
DRUG: Prednisone
DRUG: Filgrastim
DRUG: Brentuximab Vedotin
DRUG: Cyclophosphamide
DRUG: DTIC
OTHER: Quality of Life Measurements
RADIATION: Radiotherapy
DRUG: Cyclophosphamide
BIOLOGICAL: Daratumumab
DRUG: Doxorubicin
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
DRUG: Prednisone
DRUG: Vincristine
DRUG: Vincristine Sulfate
BIOLOGICAL: Nivolumab
BIOLOGICAL: favezelimab/pembrolizumab
DRUG: bendamustine
DRUG: gemcitabine
COMBINATION_PRODUCT: Pembrolizumab administered using the Sofusa® DoseConnect™
DRUG: Pirtobrutinib
DRUG: Brexucabtagene Autoleucel
DRUG: Pirtobrutinib
DRUG: Venetoclax
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
DRUG: Lenalidomide
PROCEDURE: Lumbar Puncture
PROCEDURE: Magnetic Resonance Imaging
DRUG: Methotrexate
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
PROCEDURE: Ultrasound Imaging
BIOLOGICAL: Rapcabtagene autoleucel single agent
DRUG: Ibrutinib
BIOLOGICAL: ONCT-808
DRUG: Bridging Therapy
DRUG: Low Dose Radiation Therapy
DRUG: Senza5 CART5
RADIATION: Comprehensive Ablative Bridging Irradiation (CABI)
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
BIOLOGICAL: EBV-specific T cells: A
BIOLOGICAL: EBV-specific T cells: B
DRUG: JNJ-90009530
PROCEDURE: Biospecimen Collection
PROCEDURE: Dual X-ray Absorptiometry
DRUG: Tegavivint
PROCEDURE: X-Ray Imaging
DRUG: Acalabrutinib
BIOLOGICAL: Rituximab
DRUG: Pembrolizumab
RADIATION: Involved Site Radiation Therapy
DRUG: Acalabrutinib
DRUG: SGR-1505
DRUG: CD79b-19 CAR T cells
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Itacitinib
BIOLOGICAL: Chimeric antigen receptor (CAR) T-cell therapy
RADIATION: Bridging radiation therapy
BIOLOGICAL: Liso-cel
RADIATION: Post-infusion radiation
DRUG: Axicabtagene Ciloleucel
DRUG: Venetoclax
DRUG: Lenalidomide
BIOLOGICAL: Rituximab
BIOLOGICAL: Rituximab and Hyaluronidase Human
DRUG: Zanubrutinib
BIOLOGICAL: Rituximab
OTHER: Patient Observation
PROCEDURE: Bone Marrow Biopsy
OTHER: Fludeoxyglucose F-18
PROCEDURE: Positron Emission Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Esophagogastroduodenoscopy
PROCEDURE: Colonoscopy
PROCEDURE: Biospecimen Collection
OTHER: Questionnaire Administration
DRUG: AS-1763
DRUG: CC-220
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: CC-99282
DRUG: Polatuzumab vedotin
DRUG: Rituximab
DRUG: IMPT-314
DRUG: AC676
DRUG: NKTR-255 at 1.5 µg/kg
DRUG: NKTR-255 at 3.0 μg/kg
DRUG: NKTR-255 at 3.0/6.0 μg/kg
OTHER: Placebo Comparator
DRUG: FT522
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Bendamustine
DRUG: IMT-009
COMBINATION_PRODUCT: Fruquintinib
DRUG: Polatuzumab vedotin
DRUG: Rituximab
DRUG: CHP
DRUG: NX-1607
DRUG: Paclitaxel
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter
PROCEDURE: Single Photon Emission Computed Tomography
BIOLOGICAL: Cemiplimab
DRUG: maplirpacept (PF-07901801)
DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: UVADEX® (methoxsalen) Sterile Solution in conjunction with the THERAKOS® CELLEX Photopheresis
DEVICE: THERAKOS® CELLEX photopheresis system
BIOLOGICAL: Mosunetuzumab
BIOLOGICAL: Obinutuzumab
DRUG: Polatuzumab Vedotin
DRUG: L-Bcl-2 antisense oligonucleotide
DRUG: JNJ-80948543
DRUG: N803
BIOLOGICAL: CD19t-haNK suspension
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Rituximab
DRUG: Glofitamab
DRUG: Polatuzumab
DRUG: Rituximab
DRUG: Doxorubicin Hydrochloride
DRUG: Cyclophosphamide
DRUG: Prednisone
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Etoposide
BIOLOGICAL: Loncastuximab Tesirine
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
PROCEDURE: Echocardiography
DRUG: Etoposide Phosphate
BIOLOGICAL: Filgrastim
PROCEDURE: Lumbar Puncture
BIOLOGICAL: Nivolumab
BIOLOGICAL: Pegfilgrastim
PROCEDURE: Positron Emission Tomography
DRUG: Prednisolone
DRUG: Prednisone
RADIATION: Radiation Therapy
BIOLOGICAL: Rituximab
BIOLOGICAL: Rituximab and Hyaluronidase Human
DRUG: Vincristine Sulfate
DRUG: SC262
DRUG: Nanatinostat in combination with valganciclovir
DEVICE: CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
DRUG: Palbociclib
DRUG: Sunitinib
DRUG: Temsirolimus
DRUG: Trastuzumab and Pertuzumab
DRUG: Vemurafenib and Cobimetinib
DRUG: Regorafenib
DRUG: Olaparib
DRUG: Pembrolizumab
DRUG: Nivolumab and Ipilimumab
DRUG: Abemaciclib
DRUG: Talazoparib
DRUG: Atezolizumab and PHESGO
DRUG: Atezolizumab and Talazoparib
DRUG: Entrectinib
DRUG: Larotrectinib
DRUG: Tucatinib plus Trastuzumab Subcutaneous (SC)
DRUG: Futibatinib
DRUG: Mosunetuzumab
DRUG: Tazemetostat Pill
DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: Tocilizumab
BIOLOGICAL: JNJ-90014496
BIOLOGICAL: huCART19-IL18
DRUG: STP938
BIOLOGICAL: PIT565
DRUG: PAXALISIB
DRUG: Obinutuzumab
DRUG: Glofitamab
BIOLOGICAL: Loncastuximab Tesirine
GENETIC: CB-010
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter
PROCEDURE: Single Photon Emission Computed Tomography
BIOLOGICAL: Cemiplimab
BIOLOGICAL: Ipilimumab
BIOLOGICAL: Anti-CD19-CAR CMV-specific T-lymphocytes
PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Myeloablative Conditioning
DRUG: AZD3470
DRUG: brentuximab vedotin
DRUG: brentuximab vedotin
DRUG: brentuximab vedotin
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: anti-CD19 CAR-T cells
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Lenalidomide
BIOLOGICAL: Mosunetuzumab
DRUG: Polatuzumab Vedotin
PROCEDURE: Positron Emission Tomography
DRUG: Golcadomide
DRUG: Placebo
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: ONM-501
DRUG: Cemiplimab
DRUG: Mosunetuzumab
DRUG: DHAX
DRUG: ICE
BIOLOGICAL: TmCD19-IL18
DRUG: Bexarotene
RADIATION: Total Skin Electron Beam (TSEB)
BIOLOGICAL: GEN3017
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
BIOLOGICAL: Tocilizumab
DRUG: Methotrexate
DRUG: Rituximab
DRUG: leucovorin
DRUG: Glucarpidase
DEVICE: Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine
RADIATION: Radiation - Dose Level 0
RADIATION: Radiation - Dose Level 1
RADIATION: Radiation - Dose Level 2
RADIATION: Radiation - Dose Level 3
RADIATION: Radiation - Dose Level 4
DRUG: Rituximab
DRUG: Pirtobrutinib
DRUG: Tulmimetostat
DRUG: Rituximab Prednisone
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: cemiplimab
DRUG: odronextamab
DRUG: SYNCAR-001
DRUG: STK-009
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Pembrolizumab
DRUG: Glofitamab
DRUG: Polatuzumab vedotin
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Prednisone
DRUG: Zanubrutinib
DRUG: Rituximab
DRUG: Lenalidomide
DRUG: Obinutuzumab
BIOLOGICAL: P-CD19CD20-ALLO1
DRUG: Rimiducid
BIOLOGICAL: GEN3014
DRUG: Daratumumab
BIOLOGICAL: Pembrolizumab Coformulated With Hyaluronidase
DRUG: Brentuximab vedotin
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Doxorubicin
PROCEDURE: Echocardiography
DRUG: Etoposide
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
DRUG: Prednisone
DRUG: Vincristine
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Duvelisib
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
PROCEDURE: Punch Biopsy
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
PROCEDURE: Biospecimen Collection
DRUG: Granulocyte Colony-Stimulating Factor
DRUG: Hematopoietic Cell Transplantation Conditioning Regimen
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Pheresis
DRUG: Placebo Administration
DRUG: Stem Cell Mobilization Therapy
RADIATION: Adaptive Bridging Radiation Therapy (ABRT)
DRUG: Loncastuximab Tesirine
DRUG: Polatuzumab Vedotin
DRUG: Glofitamab
DRUG: Mosunetuzumab
DRUG: Obinutuzumab
DRUG: Prednisone
DRUG: Prednisolone
DRUG: Methylprednisolone
BIOLOGICAL: Rituximab
DRUG: Polatuzumab Vedotin
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: SGN-35T
BIOLOGICAL: CTX131
DRUG: LP-118
BIOLOGICAL: Pembrolizumab
DRUG: Obinutuzumab
DRUG: Liposomal ARA-C
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide
DRUG: SIM1811-03
DRUG: Epcoritamab
DRUG: Venetoclax
DRUG: Tazemetostat
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Nelarabine
DRUG: Pegaspargase
DRUG: Prednisone
DRUG: Venetoclax
DRUG: Vincristine Sulfate
DRUG: cemsidomide
DRUG: Dexamethasone Oral
DRUG: alpha beta depletion
DRUG: Pembrolizumab
DRUG: Lymphodepletion Chemotherapy
DRUG: Chimeric Antigen Receptor (CAR) Therapy Infusion
PROCEDURE: Leukapheresis
BIOLOGICAL: CD30.CAR-EBVST cells
DRUG: Ibrutinib
BIOLOGICAL: Obinutuzumab
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Anti-CD19 CAR-T cells
DRUG: Brentuximab vedotin
DRUG: Doxorubicin
DRUG: Vinblastine
DRUG: Dacarbazine
DRUG: Pembrolizumab
DRUG: Gemcitabine
DRUG: Vinorelbine
DIAGNOSTIC_TEST: FDG-PET/CT scan
DRUG: DR-01
BIOLOGICAL: BAFFR-CAR T cells
DRUG: PRT2527
DRUG: Zanubrutinib
DRUG: Venetoclax
DRUG: Duvelisib
DRUG: Selinexor (combination therapy)
DRUG: Selinexor (combination therapy)
DRUG: Selinexor (combination therapy)
DRUG: Placebo matching for Selinexor (combination therapy)
DRUG: Rituximab (combination therapy)
DRUG: Rituximab (combination therapy)
DRUG: Gemcitabine (combination therapy)
DRUG: Dexamethasone (combination therapy)
DRUG: Cisplatin (combination therapy)
DRUG: Selinexor (continuous therapy)
DRUG: Placebo matching for Selinexor (continuous therapy)
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
BIOLOGICAL: Filgrastim
DRUG: Ibrutinib
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pegfilgrastim
OTHER: Pharmacological Study
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
BIOLOGICAL: Blinatumomab
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
BIOLOGICAL: Inotuzumab Ozogamicin
OTHER: Laboratory Biomarker Analysis
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine
DRUG: BMF-219
DRUG: NX-5948
DRUG: Vactosertib
DRUG: Fludarabine Phosphate
DRUG: Cyclophosphamide
DRUG: IL-2
DRUG: Natural Killer Cells
DRUG: PRO1160
DRUG: Belantamab Mafodotin
DRUG: MGD024
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: Zanubrutinib
DRUG: ATG-031
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
BIOLOGICAL: EGFRt/19-28z/IL-12 CAR T-lymphocytes
DRUG: Fludarabine Phosphate
PROCEDURE: Leukapheresis
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: WU-CART-007
GENETIC: cemacabtagene ansegedleucel
BIOLOGICAL: ALLO-647
DRUG: Fludarabine
DRUG: Cyclophosphamide
DEVICE: Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™
BIOLOGICAL: Nivolumab
DRUG: Oral Azacitidine
DRUG: Belinostat Injection
DRUG: Pralatrexate Injection
DRUG: CHOP
DRUG: COP
DRUG: Odronextamab
DRUG: REGN5837
DRUG: Polatuzumab vedotin (PV)
DRUG: Rituximab
DRUG: Hyaluronidase
DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Dexamethasone
DRUG: GCSF
BIOLOGICAL: HSCT with TBI Regimen
BIOLOGICAL: HSCT with Non-TBI Regimen
BIOLOGICAL: 8/12-Day Production of Car-T Cells
BIOLOGICAL: 8/12-Day Production of Cryopreserved Car-T Cells
BIOLOGICAL: 12-Day Production of Car-T Cells
RADIATION: Focal radiation therapy (RT)
DRUG: ATG-101
DRUG: CAR.k.28
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Bendamustine
DRUG: Odronextamab
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone/Prednisolone
DRUG: Epcoritamab
DRUG: Rituximab
DRUG: Lenalidomide
DRUG: Epcoritamab
DRUG: Lenalidomide
DRUG: Ibrutinib
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride [HCl]
DRUG: Prednisone
DRUG: Polatuzumab Vedotin
DRUG: Venetoclax
DRUG: CC-99282
DRUG: Epcoritamab
DRUG: Cyclophosphamide
DRUG: Rituximab
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Prednisone
DRUG: Acalabrutinib
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
BIOLOGICAL: Glofitamab
PROCEDURE: Multigated Acquisition Scan
BIOLOGICAL: Obinutuzumab
PROCEDURE: Positron Emission Tomography
DRUG: Fenretinide
DRUG: Acalabrutinib
DRUG: ATRA
DRUG: Pembrolizumab
DRUG: CPI-0209
DRUG: Mosunetuzumab
DRUG: Polatuzumab
BIOLOGICAL: CAR-T Cell Therapy
BIOLOGICAL: ATLCAR.CD30.CCR4 cells
BIOLOGICAL: ALTCAR.CD30 cells
DRUG: Bendamustine
DRUG: Fludarabine
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Rituximab
DRUG: Vincristine
DRUG: Prednisone
DRUG: Loncastuximab Tesirine 0.075 mg/kg by IV
DRUG: Loncastuximab tesirine 0.12 mg/kg by IV
DRUG: Loncastuximab tesirine 0.15 mg/kg by IV
![newsletter icon](https://static.healthtree.org/icons/newsletter-icon.png)
Get the latest thought leadership on your Leukemia delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.